sansureglobal.comCrawled Nov 3, 2026
Sansure Biotech is a service provider for the development, production and sales of diagnostic reagents and instruments, including genetic test kits, etc.
Sansure develops molecular diagnostics and genetic testing technologies for in vitro diagnostic products.
Sansure and UNICEF Mongolia signed a **Memorandum of Understanding** in December 2025 to formalize a partnership aimed at improving maternal and child health in Mongolia. The collaboration integrates Sansure’s medical expertise with UNICEF’s regional initiatives to enhance healthcare outcomes for women and children. This alliance focuses on developing safeguards and interventions tailored to local needs.
Dec 2025Sansure BiotechNews article
Sansure expands its presence in Malaysia by participating in the **World Health Expo Kuala Lumpur**, Asia’s largest medical laboratory exhibition. The three-day event drew over **450 exhibitors and 10,000 attendees**, positioning it as a key platform for Chinese healthcare brands entering Southeast Asia. Sansure engages with professionals to promote its infectious disease diagnostics and broader public health solutions, reinforcing its regional growth strategy.
Jul 2025Sansure BiotechNews article
Sansure Biotech Inc. completes the acquisition of Zhongshan Sinobioway Hygene Biomedicine Co., Ltd. from a group of sellers. The deal expands Sansure’s portfolio in biomedical hygiene solutions. No further financial or operational details are disclosed in the announcement.
Jan 2025MarketScreenerNews article
Sansure Biotech partners with UBC to establish localized manufacturing in Indonesia, deploying its molecular diagnostic technologies. The collaboration, witnessed by Indonesia’s Minister of Health and Coordinating Minister of Maritime Affairs, marks a shift toward on-site production. This move aims to improve diagnostic accuracy and treatment access in the region.
Nov 2022Sansure BiotechNews article